webinar register page

Webinar: Harnessing the T-cell response against cancer mutations
T cells are a type of white blood cell in our bodies that keep us safe from microscopic invaders like viruses and bacteria. During the last several decades, it has become clear that some T cells can recognize and kill cancer cells.

In this webinar, Eric will describe our current understanding of how T cells target cancer cells. He will also highlight one type of immunotherapy called adoptive T-cell therapy and explain how this approach is being tested in clinical trials to treat patients with cancer, including cholangiocarcinoma.

Mar 23, 2023 04:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Cholangiocarcinoma Foundation.